Results 201 to 210 of about 77,046 (263)

Long-acting lipegfilgrastim and antimicrobials as vigorous primary prophylaxis in bendamustine-treated patients with indolent B cell non-Hodgkin lymphoma: a multicentric real-life experience. [PDF]

Support Care Cancer
Giordano C, Picardi M, Vincenzi A, Scarpa A, Lombardi A, Carchia M, Damiano V, Bianco R, Trastulli F, Ronconi F, Annunziata M, Pane F.   +11 more
europepmc   +1 more source

Ankyloblepharon‐ectodermal defects‐cleft lip/palate syndrome: a case report highlighting the importance of clinical diagnosis in a rare hereditary disorder

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Aikaterini Kyriakou, Parthena Meltzanidou, Anthoula Chatzikyriakidou, Despoina Pelagidou, Antonios Fantakis, Athina‐Ioanna Daponte, Aikaterini Patsatsi, Elizabeth Lazaridou   +7 more
wiley   +1 more source

Immune checkpoint inhibitor‐induced eosinophilic fasciitis: A pharmacovigilance and EADV Task force study

Journal of the European Academy of Dermatology and Venereology, EarlyView.
A comprehensive retrospective analysis of 121 immune checkpoint inhibitor‐induced eosinophilic fasciitis cases, including clinical presentation, diagnostic features and treatment outcomes using data from the EADV Task Force ‘Dermatology for Cancer Patients’, two international pharmacovigilance databases and the current literature.
Tristan V. M. Bruijn, Alexandre O. Gérard, Maëlys Labat, Zoe Apalla, Wouter van Binsbergen, Dimitra Koumaki, Valerian Rivet, Frederic Dezoteux, Damien Giacchero, Michael R. Ardern‐Jones, Kara Heelan, Jesse P. Hirner, Ander Mayor, Mariette Labots, Markus V. Starink, Conny J. van der Laken, Vincent Sibaud, Yannick S. Elshot   +17 more
wiley   +1 more source

Incidence of severe COVID-19 in patients with chronic lymphocytic leukaemia or indolent B-cell non-Hodgkin lymphoma who received vaccination and pre-exposure prophylaxis with tixagevimab and cilgavimab in Italy: An observational study by the GIMEMA working party on chronic lymphoproliferative disorders and by the Fondazione Italiana Linfomi. [PDF]

Br J Haematol
Rigolin GM, Soddu S, Dondolin R, Frustaci AM, Scortechini I, Mauro FR, Angotzi F, Motta M, Scarfò L, Mengarelli A, Giordano A, Martinelli S, Patti C, Sportoletti P, Sanna A, Maschio N, Riccioni R, Viganò CV, Tafuri A, Piciocchi A, Fazi P, Luminari S, Ferreri AJM, Gini G, Ghia P, Cuneo A.   +25 more
europepmc   +1 more source

Current Treatment Strategies and Supportive Care Practices in the Care of Children and Adolescents With Mature B-Cell Non-Hodgkin Lymphoma: A Survey of Children's Oncology Group Institutions. [PDF]

Pediatr Blood Cancer
Belsky JA, Smith CM, Alexander S.
europepmc   +1 more source

Pediatric B-cell Non-Hodgkin Lymphoma: The Impact of Therapy Response and Relapse on Outcome. A Single-center Analysis. [PDF]

In Vivo
Stankiewicz J, Jabłońska A, Treichel P, Demidowicz E, Styczyński J.   +4 more
europepmc   +1 more source

Concurrent papillary thyroid carcinoma and incidental cervical lymph node indolent B cell non-Hodgkin lymphoma: clinicopathological features, outcomes, and potential relationships. [PDF]

World J Surg Oncol
Zhang Y, Song Y, Cheng R, Zhai Q.
europepmc   +1 more source

Linfoma não Hodgkin de células B do seio etmoidal B-cell non-Hodgkin lymphoma of the ethmoid sinus

Brazilian Journal of Otorhinolaryngology, 2013
Paulo Tinoco, José Carlos Oliveira Pereira, Flavia Rodrigues Ferreira, Vânia Lúcia Carrara, Marina Bandoli de Oliveira Tinoco   +4 more
doaj  

B-cell non Hodgkin lymphoma of the breast.

JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR), 2002
K, Joossens, A, Van Steen, C, Van Ongeval   +2 more
openaire   +1 more source